Literature DB >> 30389354

Neutral ceramidase: Advances in mechanisms, cell regulation, and roles in cancer.

Nicolas Coant1, Yusuf A Hannun2.   

Abstract

Extensive research conducted in the last three decades has identified the roles for the main bioactive sphingolipids, namely ceramide, sphingosine, and sphingosine 1-phosphate (S1P) as key regulators of cellular homeostasis, growth and death. One of the major groups of enzymes in the ceramide pathway, ceramidases, converts ceramide into sphingosine and fatty acids, with sphingosine being further metabolized to S1P. Thus, these enzymes play important roles in the network controlling the functions associated with these bioactive sphingolipids. Among the family of ceramidases, neutral ceramidase (nCDase), which is named according to its optimal pH for catalytic activity, has received increased attention in the last decade. The goal of this review is to provide a brief background on bioactive sphingolipids and the ceramidases. We then describe more recent advances on nCDase, specifically the resolution of its crystal structure and understanding its roles in cell biology and physiology.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Akt; Cancer; Catalysis; Cell proliferation; Sphingolipids; Sphingosine; Structure

Mesh:

Substances:

Year:  2018        PMID: 30389354      PMCID: PMC6347532          DOI: 10.1016/j.jbior.2018.10.005

Source DB:  PubMed          Journal:  Adv Biol Regul        ISSN: 2212-4926


  39 in total

1.  Development of a novel FRET probe for the real-time determination of ceramidase activity.

Authors:  Krishna P Bhabak; Anett Hauser; Susanne Redmer; Sebastian Banhart; Dagmar Heuer; Christoph Arenz
Journal:  Chembiochem       Date:  2013-05-31       Impact factor: 3.164

2.  Hydrolytic pathway protects against ceramide-induced apoptosis in keratinocytes exposed to UVB.

Authors:  Yoshikazu Uchida; Evi Houben; Kyungho Park; Sounthala Douangpanya; Yong-Moon Lee; Bill X Wu; Yusuf A Hannun; Norman S Radin; Peter M Elias; Walter M Holleran
Journal:  J Invest Dermatol       Date:  2010-06-03       Impact factor: 8.551

Review 3.  Sphingolipids and their metabolism in physiology and disease.

Authors:  Yusuf A Hannun; Lina M Obeid
Journal:  Nat Rev Mol Cell Biol       Date:  2017-11-22       Impact factor: 94.444

4.  Purification and characterization of a membrane-bound nonlysosomal ceramidase from rat brain.

Authors:  S El Bawab; A Bielawska; Y A Hannun
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

5.  Structural Basis for Ceramide Recognition and Hydrolysis by Human Neutral Ceramidase.

Authors:  Michael V Airola; William J Allen; Michael J Pulkoski-Gross; Lina M Obeid; Robert C Rizzo; Yusuf A Hannun
Journal:  Structure       Date:  2015-07-16       Impact factor: 5.006

6.  Upregulation of the human alkaline ceramidase 1 and acid ceramidase mediates calcium-induced differentiation of epidermal keratinocytes.

Authors:  Wei Sun; Ruijuan Xu; Wei Hu; Junfei Jin; Heather A Crellin; Jacek Bielawski; Zdzislaw M Szulc; Bruce H Thiers; Lina M Obeid; Cungui Mao
Journal:  J Invest Dermatol       Date:  2007-08-23       Impact factor: 8.551

7.  Palmitate inhibition of insulin gene expression is mediated at the transcriptional level via ceramide synthesis.

Authors:  Cynthia L Kelpe; Patrick C Moore; Susan D Parazzoli; Barton Wicksteed; Christopher J Rhodes; Vincent Poitout
Journal:  J Biol Chem       Date:  2003-05-27       Impact factor: 5.157

8.  AKT as a key target for growth promoting functions of neutral ceramidase in colon cancer cells.

Authors:  Nicolas Coant; Mónica García-Barros; Qifeng Zhang; Lina M Obeid; Yusuf A Hannun
Journal:  Oncogene       Date:  2018-04-17       Impact factor: 9.867

Review 9.  Roles of Sphingolipid Metabolism in Pancreatic β Cell Dysfunction Induced by Lipotoxicity.

Authors:  Julien Véret; Lara Bellini; Paola Giussani; Carl Ng; Christophe Magnan; Hervé Le Stunff
Journal:  J Clin Med       Date:  2014-06-20       Impact factor: 4.241

10.  A neutral ceramidase, NlnCDase, is involved in the stress responses of brown planthopper, Nilaparvata lugens (Stål).

Authors:  Xiao-Xiao Shi; Yuan-Jie Huang; Mahfuj-Ara Begum; Mu-Fei Zhu; Fei-Qiang Li; Min-Jing Zhang; Wen-Wu Zhou; Cungui Mao; Zeng-Rong Zhu
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

View more
  11 in total

1.  Design, Synthesis, and Biological Evaluation of a Series of Oxazolone Carboxamides as a Novel Class of Acid Ceramidase Inhibitors.

Authors:  Samantha Caputo; Simona Di Martino; Vincenzo Cilibrasi; Piero Tardia; Marco Mazzonna; Debora Russo; Ilaria Penna; Maria Summa; Sine Mandrup Bertozzi; Natalia Realini; Natasha Margaroli; Marco Migliore; Giuliana Ottonello; Min Liu; Peter Lansbury; Andrea Armirotti; Rosalia Bertorelli; Soumya S Ray; Renato Skerlj; Rita Scarpelli
Journal:  J Med Chem       Date:  2020-12-08       Impact factor: 7.446

Review 2.  Targeting Sphingolipid Metabolism as a Therapeutic Strategy in Cancer Treatment.

Authors:  Alhaji H Janneh; Besim Ogretmen
Journal:  Cancers (Basel)       Date:  2022-04-27       Impact factor: 6.575

Review 3.  Neutral ceramidase: Advances in mechanisms, cell regulation, and roles in cancer.

Authors:  Nicolas Coant; Yusuf A Hannun
Journal:  Adv Biol Regul       Date:  2018-10-26

4.  Ceramide synthase 2-C24:1 -ceramide axis limits the metastatic potential of ovarian cancer cells.

Authors:  Xuewei Zhang; Wataru Sakamoto; Daniel Canals; Masumi Ishibashi; Masaya Matsuda; Kentaro Nishida; Masafumi Toyoshima; Shogo Shigeta; Makoto Taniguchi; Can E Senkal; Toshiro Okazaki; Nobuo Yaegashi; Yusuf A Hannun; Takeshi Nabe; Kazuyuki Kitatani
Journal:  FASEB J       Date:  2021-02       Impact factor: 5.191

5.  Asah2 Represses the p53-Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis.

Authors:  Huabin Zhu; John D Klement; Chunwan Lu; Priscilla S Redd; Dafeng Yang; Alyssa D Smith; Dakota B Poschel; Juan Zou; Ding Liu; Peng George Wang; David Ostrov; Nicolas Coant; Yusuf A Hannun; Aaron H Colby; Mark W Grinstaff; Kebin Liu
Journal:  J Immunol       Date:  2021-02-05       Impact factor: 5.422

Review 6.  Elusive Roles of the Different Ceramidases in Human Health, Pathophysiology, and Tissue Regeneration.

Authors:  Carolina Duarte; Juliet Akkaoui; Chiaki Yamada; Anny Ho; Cungui Mao; Alexandru Movila
Journal:  Cells       Date:  2020-06-02       Impact factor: 6.600

7.  Neutral ceramidase deficiency protects against cisplatin-induced acute kidney injury.

Authors:  Sophia M Sears; Tess V Dupre; Parag P Shah; Deanna L Davis; Mark A Doll; Cierra N Sharp; Alexis A Vega; Judit Megyesi; Levi J Beverly; Ashley J Snider; Lina M Obeid; Yusuf A Hannun; Leah J Siskind
Journal:  J Lipid Res       Date:  2022-02-10       Impact factor: 5.922

Review 8.  Involvement of Ceramide Metabolism in Cerebral Ischemia.

Authors:  Alberto Ouro; Clara Correa-Paz; Elena Maqueda; Antía Custodia; Marta Aramburu-Núñez; Daniel Romaus-Sanjurjo; Adrián Posado-Fernández; María Candamo-Lourido; Maria Luz Alonso-Alonso; Pablo Hervella; Ramón Iglesias-Rey; José Castillo; Francisco Campos; Tomás Sobrino
Journal:  Front Mol Biosci       Date:  2022-04-20

9.  Neutral ceramidase is a marker for cognitive performance in rats and monkeys.

Authors:  Liubov S Kalinichenko; An-Li Wang; Christiane Mühle; Joseph P Huston; Laila Abdel-Hafiz; Erich Gulbins; Johannes Kornhuber; André W C Oliveira; Marilia Barros; Christian P Müller
Journal:  Pharmacol Rep       Date:  2020-09-16       Impact factor: 3.024

Review 10.  Ceramide Metabolism and Parkinson's Disease-Therapeutic Targets.

Authors:  Antía Custodia; Marta Aramburu-Núñez; Clara Correa-Paz; Adrián Posado-Fernández; Ana Gómez-Larrauri; José Castillo; Antonio Gómez-Muñoz; Tomás Sobrino; Alberto Ouro
Journal:  Biomolecules       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.